NP / PA
Spangler, Kevin
Spangler, Kevin was paid $248K by Medicaid between Feb 2019 and Dec 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 65% of everything it billed.
33Billing provider infoSPANGLER, KEVIN
PEORIA HEIGHTS, IL 61616
PEORIA HEIGHTS, IL 61616
33aNPI1659790350assigned 04/09/2014
33bProvider typeFamily Nurse Practitioner
28Total paid$248K
24GClaims5,143
24DCodes billed12
24AFirst – last monthFeb 2019 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#255 of 3,353
Median peer was paid$25K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 143 | $7K | |
| 2021 | 617 | $26K | |
| 2022 | 1,329 | $62K | |
| 2023 | 1,647 | $75K | |
| 2024incomplete | 1,407 | $77K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 65% | 3,397 | 3,220 | $160K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 926 | 860 | $69K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 331 | 321 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 108 | 90 | $4K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.0% | 56 | 49 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 68 | 65 | $2K |
| 87428 | <1% | 22 | 18 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 32 | 28 | $959.47 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | 16 | $820.96 |
| 81025 | <1% | 58 | 41 | $328.24 | |
| 81002 | <1% | 115 | 99 | $299.00 | |
| 87807 | <1% | 14 | 14 | $131.94 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.